日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A Phase II Trial to Evaluate the Safety and Immunogenicity of Two Doses of a Folate Receptor Alpha Vaccine in Patients with Triple-Negative Breast Cancer

一项评估两剂叶酸受体α疫苗在三阴性乳腺癌患者中安全性和免疫原性的II期临床试验

Knutson, Keith L; Abu-Fares, Hala; Keating, Patricia; Block, Matthew S; Norton, Nadine; Erskine, Courtney L; Cogen, Davitte; Assad, Hadeel; Graff, Stephanie L; Hamilton, Erika P; Han, Hyo S; McIntyre, Kristi J; Nassar, Aziza; Sparano, Joseph A; Tiersten, Amy; Tkaczuk, Katherine H; Ward, Patrick J; Wilson, Glynn; Garrett, Gerald; Kenney, Richard T; Sharma, Priyanka

Impact of race/ethnicity on MammaPrint genomic assay risk and prognosis in early breast cancer: A National Cancer Data Base analysis

种族/民族对早期乳腺癌MammaPrint基因组检测风险和预后的影响:一项基于国家癌症数据库的分析

Patel, Rima B; Sheng, Tianxiang; Diniz, Marcio A; Sparano, Joseph A; Tiersten, Amy

The Role of Immunotherapy and Radiation Therapy in the Treatment of Breast Cancer

免疫疗法和放射疗法在乳腺癌治疗中的作用

Panse, Drishti; Hsieh, Kristin; Arons, Danielle; Runnels, Juliana; Wassel, Monica; Shah, Anuja; Patel, Rima; Tiersten, Amy; Nehlsen, Anthony D; Marshall, Deborah; Samstein, Robert M; Green, Sheryl; Bloom, Julie

A Randomized Controlled Trial of Hypnosis to Manage Musculoskeletal Pain in Breast Cancer Survivors Taking Aromatase Inhibitors

一项关于催眠疗法治疗服用芳香化酶抑制剂的乳腺癌幸存者肌肉骨骼疼痛的随机对照试验

Montgomery, Guy H; Schnur, Julie B; Tiersten, Amy; Benck, Kelley; Erblich, Joel

Endocrine-Sensitive Disease Rate in Postmenopausal Patients With Estrogen Receptor-Rich/ERBB2-Negative Breast Cancer Receiving Neoadjuvant Anastrozole, Fulvestrant, or Their Combination: A Phase 3 Randomized Clinical Trial

接受新辅助阿那曲唑、氟维司群或二者联合治疗的雌激素受体丰富/ERBB2阴性绝经后乳腺癌患者的内分泌敏感性疾病发生率:一项3期随机临床试验

Ma, Cynthia X; Suman, Vera J; Sanati, Souzan; Vij, Kiran; Anurag, Meenakshi; Leitch, A Marilyn; Unzeitig, Gary W; Hoog, Jeremy; Fernandez-Martinez, Aranzazu; Fan, Cheng; Gibbs, Richard A; Watson, Mark A; Dockter, Travis J; Hahn, Olwen; Guenther, Joseph M; Caudle, Abigail; Crouch, Erika; Tiersten, Amy; Mita, Monica; Razaq, Wajeeha; Hieken, Tina J; Wang, Yang; Rimawi, Mothaffar F; Weiss, Anna; Winer, Eric P; Hunt, Kelly K; Perou, Charles M; Ellis, Matthew J; Partridge, Ann H; Carey, Lisa A

An emerging generation of endocrine therapies in breast cancer: a clinical perspective

乳腺癌内分泌治疗的新兴领域:临床视角

Patel, Rima; Klein, Paula; Tiersten, Amy; Sparano, Joseph A

Outcomes in Premenopausal Patients with HR+/HER2- Breast Cancer and Lymph Node Micrometastasis Based on the 21-Gene Recurrence Score

基于21基因复发评分的绝经前HR+/HER2-乳腺癌伴淋巴结微转移患者的预后

Bilani, Nadeem; Patel, Rima; Crowley, Fionnuala; Tiersten, Amy

Correlation of the Ki67 Working Group prognostic risk categories with the Oncotype DX Recurrence Score in early breast cancer

Ki67工作组预后风险分类与早期乳腺癌Oncotype DX复发评分的相关性

Patel, Rima; Hovstadius, Malin; Kier, Melanie W; Moshier, Erin L; Zimmerman, Brittney S; Cascetta, Krystal; Jaffer, Shabnam; Sparano, Joseph A; Tiersten, Amy

Phase I/II trial of ruxolitinib in combination with trastuzumab in metastatic HER2 positive breast cancer

鲁索替尼联合曲妥珠单抗治疗转移性HER2阳性乳腺癌的I/II期临床试验

Kearney, Matthew; Franks, Lauren; Lee, Shing; Tiersten, Amy; Makower, Della F; Cigler, Tessa; Mundi, Prabhjot; Chi, Dow-Chung; Goel, Anupama; Klein, Pam; Andreopoulou, Eleni; Sparano, Joseph; Trivedi, Meghna; Accordino, Melissa; Califano, Andrea; Hershman, Dawn L; Silva, Jose; Kalinsky, Kevin

Patient Perception of Telehealth Services for Breast and Gynecologic Oncology Care during the COVID-19 Pandemic: A Single Center Survey-based Study

新冠疫情期间患者对远程医疗在乳腺和妇科肿瘤诊疗中的应用认知:一项基于单中心调查的研究

Zimmerman, Brittney S; Seidman, Danielle; Berger, Natalie; Cascetta, Krystal P; Nezolosky, Michelle; Trlica, Kara; Ryncarz, Alisa; Keeton, Caitlin; Moshier, Erin; Tiersten, Amy